Schrödinger to Present at Morgan Stanley Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will take place on Monday, September 8, 2025 at 11:30 a.m. E.T.

The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250827688442/en/

Allie Nicodemo
Schrödinger, Inc.
[email protected]
617-356-2325

Source: Schrödinger

You May Also Be Interested In

• GMO GlobalSign Expands TLS Connect by GMO Availability, Bringing CLM Automation to Small and Medium Enterprises in APAC and the Middle East
• Argo Graphene Solutions Announces $1 Million Financing to Advance STREAM(TM) Graphene Refinery Strategy and Provides Corporate Update
• CyberCatch Announces Signing of Definitive Agreement for Datavault AI to Acquire the Company in All-Cash Transaction